Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases-Reference-Cited by-同舟云学术

Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases

Published:2014-07-18 Issue:12 Volume:74 Page:1379-1410
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Scott Lesley J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-014-0258-9.pdf

Reference204 articles.

1. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509.

2. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1: overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826–50.

3. National Institute for Health and Clinical Excellence. CG153 Psoriasis: NICE guideline. 2012. http://guidance.nice.org.uk/CG153/NICEGuidance/pdf/English . Accessed 18 Apr 2014.

4. Smith CH, Anstey AV, Barker JNWN, et al. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009;161:897–1019.

5. Strand V, Sharp V, Koenig AS, et al. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis. 2012;71(7):1143–50.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evidence of the anti‐inflammatory effect and toxicological safety of aryl‐cyclohexanone in vivo;Fundamental & Clinical Pharmacology;2024-08-18

2. VEGFA, MYC, and JUN are abnormally elevated in the synovial tissue of patients with advanced osteoarthritis;2024-08-09

3. Comparison of disease‐modifying anti‐rheumatic drugs and hyperbaric oxygen therapy in the experimental model of rheumatoid arthritis in rats;Clinical and Experimental Pharmacology and Physiology;2024-07-04

4. MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications;Heliyon;2024-04

5. TNFRSF1B Signaling Blockade Protects Airway Epithelial Cells from Oxidative Stress;Antioxidants;2024-03-18